Labcorp (LH)
(Delayed Data from NYSE)
$209.54 USD
+0.33 (0.16%)
Updated Mar 18, 2024 04:00 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Revenues: Diagnostics Laboratories
- 9,415.10
- 9,203.50
- 10,363.60
- 9,253.40
- 6,999.90
- Revenue - Line of Business (LOBR)
- Revenues: Biopharma Laboratory Services
- 2,774.20
- 5,710.20
- 5,845.50
- 4,877.70
- 4,578.10
- Revenue - Line of Business (LOBR)
- Revenues: Intercompany eliminations
- -27.70
- -36.90
- -88.20
- -152.60
- -23.40
- Income - Line of Business (LOBI)
- Adjusted Operating Income: Diagnostics Laboratories
- 1,591.30
- 2,025.50
- 3,205.60
- 2,801.30
- 1,229.10
- Income - Line of Business (LOBI)
- Adjusted Operating Income: Biopharma Laboratory Services
- 396.30
- 801.10
- 887.10
- 721.60
- 637.90
- Income - Line of Business (LOBI)
- Adjusted Operating Income: Unallocated corporate expense
- -272.70
- -468.80
- -404.50
- -226.80
- -167.30
- Non Financial / Operating Metric (NFM)
- Net orders
- 2.89
- 7.28
- 7.28
- --
- --
- Non Financial / Operating Metric (NFM)
- Net book-to-bill Ratio
- 1.04
- 1.27
- 1.25
- --
- --
- Non Financial / Operating Metric (NFM)
- Ending backlog
- 8.25
- 16.30
- 14.96
- --
- --